Sopdxh900 C06947-1aa
Sopdxh900 C06947-1aa
Sopdxh900 C06947-1aa
On the DxH 900, the complete blood count, the CBC, is the fundamental analytical test that evaluates the
three main cellular components: White Blood Cells, Red Blood Cells, and Platelets. The WBC differential,
also a fundamental test, identifies and enumerates the percent and absolute number (% & #) of the white
bloods cells and nucleated Red Blood Cells present in whole blood. The complete Retic count, an analytical
test, evaluates red cell production and maturity. The analysis of body fluids identifies and enumerates total
nucleated cells (WBC and others) and RBC and assists with the identification of reactive, infectious or
malignant processes. The DxH 900 CBC and body fluids analyses are based on the Coulter Principle. The
WBC differential, NRBC and Reticulocyte analyses use VCSn technology. The CBC with WBC differential,
NRBC, Reticulocyte and Body Fluid counts are for in vitro diagnostic use in screening patient populations
found in clinical laboratories.
This document is not intended to replace the information in the Instrument Instructions for Use Manual
(IFU). Information in the Instructions for Use Manual supersedes information in any other manual.
Principles
of the Parameter Method Description
Procedure
Coulter
UWBC
Principle
Principles
of the Parameter Method Description
Procedure
(cont.)
Principles
of the Parameter Method Description
Procedure
(cont.)
Hematocrit
The relative volume of packed erythrocytes to whole blood
Hct Calculated The HCT is calculated using any corrected RBC and/or MCV,
when appropriate.
Hct% = (RBC x MCV)/10
Principles
of the Parameter Method Description
Procedure
(cont.)
Red Cell Distribution Width – Standard Deviation
The size distribution spread of the erythrocyte population
Derived from derived from the RBC histogram. Corrected for WBC
RDW-SD
RBC Histogram interference when WBC > 140 x 103 cells/uL and the WBC
particles were observed in the RBC Histogram.
RDW-SD is expressed as a standard deviation in fL
Platelet Count
Derived from the PLT histogram, multiplied by a calibration
factor.
PLT = N x 103 cells/μL
In the RBC bath, 10 mL of DxH diluent and 1.6 μL of sample are
Coulter
PLT combined for a final dilution of 1:6250. After mixing and incubation of
Principle
sample and reagents, 6 inches of vacuum and aperture current are
applied simultaneously to the apertures for the measurements of cell
count and cell volume. The RBC and PLT count includes the
application of sweep flow to prevent the recirculation of cells behind
the aperture.
.
Mean Platelet Volume
MPV Derived from
The average volume of individual platelets as derived from the
PLT Histogram
PLT histogram after being multiplied by a calibration factor.
MPV is expressed in fL.
Principles
of the Parameter Method Description
Procedure
(cont.)
WBC WBC Differential
Diff The sample preparation for the Diff analysis occurs in the diff mix
chamber part of the Air Mix and Temperature Control (AMTC) module
of the VCSn module. Approximately 34 µL of whole blood are delivered
by the Sample Aspiration Module (SAM) and dispensed directly into the
Diff chamber. Next, approximately 548 µL of Erythrolyse are added
and mixed using a focused jet of air regulated to 4 psi. After a brief
incubation, approximately 582 µL of Stabilyse are added, stabilizing
the WBC in their near native state. The prepared Diff sample is then
transferred to the flow cell for analysis.
LY Lymphocyte Percent
• [LY events/(NE+LY+MO+EO+BA events)] x 100
• Expressed as a percentage (%)
MO Monocyte Percent
↓ • [MO events/(NE+LY+MO+EO+BA events)] x 100
• Expressed as a percentage (%)
EO Eosinophil Percent
• [EO events/NE+LY+MO+EO+BA events)] x 100
• Expressed as a percentage (%)
BA Basophil Percent
• [BA events/(NE+LY+MO+EO+BA events)] x 100
• Expressed as a percentage (%)
Principles
of the Parameter Method Description
Procedure
(cont.)
NRBC VCSn Nucleated Red Blood Cell Count
Technology • The number of nucleated red blood cells (NRBC) per 100 WBC
• Expressed as NRBC/100 WBC
The sample preparation for the NRBC analysis occurs in the NRBC mix
chamber incorporated into the Air Mix and Temperature Control
(AMTC) module of the VCSn module. Approximately 22 µL of whole
blood and 400 µL of diluent are delivered by the Sample Aspiration
Module (SAM), dispensed and mixed in the Diff chamber. Next,
approximately 155 µL of Cell Lyse is added and mixed using a focused
jet of air regulated to 4 psi. After a brief incubation, the prepared
NRBC sample is transferred to the flow cell for analysis.
Clinical The UniCel DxH 900 analyzer is a quantitative, multi-parameter, automated hematology analyzer for
Utility in-vitro diagnostic use in screening patient populations found in clinical laboratories.
Body Fluids
Beckman Coulter recommends that a diluent be run as a Body Fluid sample prior to analysis of Body
Fluid specimens. Backgrounds within specifications can influence the reported results on the samples
with low abnormal or normal values. Beckman Coulter recommends that each laboratory establish
criteria for evaluation of the impact of the background on the reported results.
To reduce body fluid sample viscosity, use hyaluronidase to treat synovial fluids prior to analysis
according to your laboratory standards. Add in the ratio of 1 mL of synovial fluid to 5 mg of
hyaluronidase. Mix for 5 minutes.
Specimen Tubes
The DxH Systems are capable of processing a wide variety of specimen tubes. See Recommended Tubes
in Appendix A, Special Equipment for tube specifications.
IMPORTANT
Refer to CLSI GP44-A4 for guidelines.
Specimen Sample stability is measured by the ability of results to be within the stated specifications for a given
Collection and period of time and storage condition. A minimum of ten (10) samples are analyzed in duplicate at time
Preparation zero and the defined temperatures in Table 1.29, Sample Stability (Whole Blood). The mean of those
(cont.) results is compared to the mean of the same samples analyzed at the times and storage conditions
noted in those tables. The difference in mean results will be within the stability ranges defined in Table
1.29, Sample Stability (Whole Blood) and Table 1.30, Sample Stability (Pre-diluted Whole Blood).
Beckman Coulter recommends analyzing all non-refrigerated whole blood samples within 24 hours.
Reagents
The following are the recommended reagents:
Refer to Setting Up DxH 900 Supplies, Replacing Reagent Containers – DxH 900 for the
recommended setup and replacement procedures listed in the Instructions for Use (IFU) or on-line help.
IMPORTANT: If product has been partially or completely frozen, allow product to warm to room
temperature. Invert the container 16 times to ensure complete mixing prior to placement on the
instrument. Install and prime the diluent as directed in your instrument product manuals and/or
online help. Verify background counts are acceptable before analyzing patient samples.
IMPORTANT: If product has been partially or completely frozen, allow product to warm to room
temperature. Mix product by gentle inversion prior to placement on the instrument. Install and prime
the reagent as directed in your instrument product manuals and/or online help. Verify background
counts are acceptable before analyzing patient samples.
IMPORTANT: If product has been partially or completely frozen, allow product to warm to room
temperature. Mix product by gentle inversion prior to placement on the instrument. Install and prime
the reagent as directed in your instrument product manuals and/or online help.
IMPORTANT: If product has been partially or completely frozen, allow product to warm to room
temperature. Mix product by gentle inversion prior to placement on the instrument. Install and prime
the reagent kit as directed in your instrument product manuals and/or online help. Verify background
counts are acceptable before analyzing patient samples.
IMPORTANT: If product has been partially or completely frozen, allow product to warm to room
temperature. Mix product by gentle inversion prior to placement on the instrument. Install and prime
the reagent kit as directed in your instrument product manuals and/or online help. Verify background
counts are acceptable before analyzing patient samples.
Materials The following reagents, calibrators and controls are recommended and not supplied but may be
Required But Not required and can be purchased separately.
Provided
COULTER 6C Cell Control PN 628027 (12x) PN A59925 (9x)
The COULTER 6C Cell Control is an integrated control that enables monitoring of system performance
for CBC, Diff and NRBC parameters.
Calibration The calibration procedure consists of comparing instrument measurements to known values for WBC,
DxH 900 RBC, HGB, MCV, PLT and MPV. Calibration assures that an instrument's data output accurately reflects
sample input. Calibration is performed using materials based on or traceable to known reference
preparations or materials. In general, the procedure may indicate that the instrument requires
standardization, by first determining the deviation from calibrator reference, and then applying
recommended correction factors (CAL factors).
The laboratory is responsible for the final calibration of the CBC parameters. Beckman Coulter
recommends COULTER S-CAL calibrator, or an exact equivalent, as an acceptable alternative to whole
blood calibration.
In the normal process of tracking data for an extended period of time, your laboratory can make a
specific decision to recalibrate a given parameter. Never adjust to a specific value for an individual
sample.
For best performance, verify and calibrate all the CBC parameters. The WBC differential, NRBC and
Retic parameters are calibrated by an authorized Beckman Coulter Representative in your laboratory.
The VCSn parameters do not require calibration in the laboratory.
NOTE: Ensure your SPM is properly maintained and the apertures are clean prior to calibration.
When to Calibrate:
You should calibrate your instrument:
• At installation
• After the replacement of any component that involves dilution characteristics (such as the BSV) or
the primary measurements (such as the apertures)
• When advised to do so by your Beckman Coulter Representative.
• If you fail verify calibration procedure.
NOTE: You can also set up an automatic notification to let you know when to calibrate. See Setting up
an Automatic Notification to Verify Calibration in Chapter 9, Setup.
Quality Control Quality Control is the routine monitoring of performance and service using commercial or patient
DxH 900 controls. Controls have known characteristics when run on a given system and are analyzed
periodically in the same manner that patient specimens are analyzed. The results of analyzed controls
are then compared to the known characteristics using statistical methods. This comparison allows
changes in the system performance to be detected. You can then take some action if the changes
detected are significant.
The DxH 900 system lets you use multiple quality control techniques that are outlined in Chapter 4,
Quality Control of the Instructions for Use. Beckman Coulter recommends that Quality Control checks
be performed using patient and/or commercial controls at intervals established by your lab. When
using a commercial control, refer to the package insert to determine which method of presentation to
use. Failure to recover control values within your lab’s expected limits or the presence of unexplained
shifts or trends in any method of presentation should be investigated. If control problems cannot be
resolved, call your Beckman Coulter Representative.
Timely Quality Control monitoring includes Intelligent Quality Monitoring (IQM), which monitors event
notification and recovery within the system on an on-going basis. IQM monitors sensor and hardware
status in real-time, and also provides tracking and trending of event notifications via the Alert Status
icons, alarms and the History Event Log > QC tab. Events can be addressed as they occur. The
availability of IQM optimizes system availability and minimizes possible repeat patient testing for failed
QC. The combination of these methods provides the assurance of complete quality control and should
be applied separately or in combination, in accordance with your laboratory and accreditation
requirements.
Scanning New Beckman Coulter Controls from a Handheld Bar Code Scanner
1. To set up a new Beckman Coulter control using the handheld bar code reader, follow the
instructions below.
2. From the Quality Control Setup - Controls screen, select New Control from Bar Code. The
following message is displayed: Waiting for 2D bar code to be scanned from assay sheet. Scan
the bar code.
3. After you scan the bar code, a dialog box is displayed that lets you select Auto Stop, Auto Print
and Auto Transmit for selected control files and instruments. The default selections are all files
and all instruments, but no Auto Stop, Auto Print or Auto Transmit.
NOTE: If you enter a Beckman Coulter Control manually and you enter an incorrect level, source,
or type, the control file must be deleted and you must enter the control again.
Procedure 4. Enter a Lot Number (without hyphens) and select an Expiration Date from the drop-down
Setting list.
Up Controls 5. Select from the options available:
(cont). a. Auto Transmit
b. Auto Stop
c. Auto Print
6. Enter the Target and Limit values for the parameters, or choose from the Assigned Target
and Expected Limit options available on the screen.
7. Select Save to save the control settings.
Procedure Preparing COULTER LATRON CP-X AND COULTER 6C, Body Fluid, and Retic-X Controls
Processing
Controls COULTER LATRON CP-X
1. Bring COULTER LATRON CP-X to ambient temperature before use.
2. Gently mix a room temperature tube of COULTER LATRON CP-X Control by inversion five (5) to
eight (8) times. Avoid foaming.
Processing COULTER LATRON CP-X, COULTER 6C Cell, Retic-X Cell, and Body Fluid Controls
1. Prepare your instrument: Follow the instructions for Setting Up Controls in System HELP or the
Instructions for Use when a new lot of controls is received.
2. Perform Daily Checks according to System HELP or the Instructions for Use.
3. Place controls in cassette and place cassette in the Input Buffer.
4. Process the Latron, 6C and Retic-X controls in the Cassette Presentation on the instrument. For
Latron, examine the Mean/Mode Channel and Coefficient of Variation results for the volume,
conductivity and various light scatter measurements. Compare the results to the TABLE OF
EXPECTED RESULTS.
5. Process the Body Fluids Control in the Single-Tube Presentation on the instrument.
6. For 6C, Retic-X, and Body Fluid Controls compare instrument values to those given in the
TABLE OF EXPECTED RESULTS.
7. Return the tube(s) to the refrigerator within 30 minutes.
NOTE: If a result exceeds the assay limits, refer to your System HELP or Instructions for Use for
suggested actions. Follow your laboratory’s procedure for handling results that exceed limits.
IQAP Export 1. Select Menu > Setup > Quality Control > More Options > IQAP Export.
Setup 2. Select Export IQAP.
NOTE Batching must be disabled in order to manually add a test order. Batching can be
enabled/disabled by module. See Batching in Chapter 9, Setup for additional instructions.
3. Press [Tab] to move through each section and follow the steps for Add Specimen Information,
Select an Available Panel, and Add Patient Information.
1. Verify or select the panel. See Table 5.1, Available Panels for a list of available panels. You
can add patient information at this time, if desired.
NOTE Select None for samples without a test order when your system is using the LIS to populate
the worklist. The samples without test orders will be skipped.
2. Select Submit.
NOTE Orders that are added to the system, but have not yet been analyzed, can be viewed on the
Worklist - Pending screen.
2. Select a Patient ID, then OK to add the patient’s demographics to the order
OR
Select Add Patient to add a new patient demographic to the database.
NOTE To edit a patient’s demographics, select Edit Patient. See Demographics in Chapter 9,
Setup for additional instructions.
Sample Analysis When a Patient demographic is associated with the test order, a Patient button is enabled from the
(cont.) local navigation bar on the Add Order and Edit Order screens which lets you select from the following
options. Select OK when the dialog box is displayed to confirm the action.
• Clear Patient: Lets you disassociate the currently selected patient from the Test Order. In other
words, it clears the patient demographic.
• Edit Patient: Displays the Edit Patient Demographics Dialog. Lets you edit all of the patient
demographics with the exception of the Patient ID.
• Rectify Patient ID: Lets you enter the correct patient ID (in case the patient ID is wrong). See
Rectify Patient ID in Chapter 9, Setup for additional information.
Cassette Presentation
1. Ensure the SPM is set up for the appropriate test for your workflow. For additional information
on manually adding a test order to the worklist, see Test Orders in Chapter 5, Sample Analysis.
2. Ensure your specimens have been:
• Collected properly
• Stored and handled properly
3. Load the specimens into the cassettes.
4. Place the cassettes into the Input Buffer. The SPM automatically begins cycling the cassettes.
5. After the SPM cycles the samples, review the sample results at the System Manager. See
Chapter 6, Data Review for information on reviewing sample results.
NOTE If the bar code label is unreadable, try moving the tube off the indentation and nearer to the
camera for a re-scan attempt.
OR
OR
Scan the bar code with the handheld scanner. See Using the Handheld Scanner in Chapter 5,
Sample Analysis for additional instructions.
6. Verify the Specimen Identifier and submit a Test request, if prompted to do so.
7. Select the Control checkbox if you are running a Body Fluid control.
8. Press [Enter] to indicate that you accept the bar code label read or a manual entry.
9. Mix the specimen according to your laboratory standards.
10. Place the specimen into the desired position of the Single-Tube Station. The Single-Tube
Station will retract into the instrument and begin analysis. The system will provide information
on the state of the instrument.
IMPORTANT If more than two minutes elapse from the time the Specimen ID is entered to the time
the specimen is placed into the Single-Tube Station, the station will retract and the System Manager
will exit the Single-Tube Presentation. If you do not remove the completed sample from the Single-
Tube Station, the station will retract and the System Manager will exit Single-Tube Presentation. Re-
enter the Single-Tube Presentation to retrieve any tube that remained in the Single-Tube Station after
retraction.
NOTE At any time during single-tube analysis, the Single-Tube Presentation screen may be hidden by
selecting Hide. Display the screen on again by selecting the Single-Tube Presentation icon.
Retrieve the tube from the Single-Tube Station. Select Exit and Yes from the dialog box to end the
single-tube analysis. Return any offline SPM to the online state.
Running Samples Your DxH handheld scanner is a camera that takes a picture of the bar code.
(cont.) 1. Aim the scanner at the bar code as if you were taking a picture.
2. Slowly move the scanner closer to the bar code (allow the camera to focus) until you hear a
beep. If you do not hear a beep, ensure that the scanner is correctly connected to the
computer and configured for your labels.
PREDIx5 provides a CBC analyzed via Single-Tube Presentation. The dilution factor is set to 5. The
Single-Tube Presentation requires 165 μL. For analysis and pre-dilute preparation, 50 μL whole blood
in 200 μL diluent are required for analysis and pre-dilute preparation.
The diluted sample results analyzed using the PREDIx5 panel and Single-Tube Presentation are
automatically multiplied by 5.
A simple dilution is one in which a unit of sample volume is combined with the appropriate volume of
diluent to achieve a desired concentration. The dilution factor is the total number of unit volumes in
which the blood sample will be dissolved. For example, a 1:2 dilution combines one (1) unit volume of
blood sample and one (1) unit volume of diluent. The results dilution factor is two (2 = 1 + 1).
Obtain Diluent
1. Have a clean empty tube ready to collect the dispensed diluent.
2. Select .
3. Select Dispense Diluent and follow the prompts on the screen to acquire diluent
(approximately 1 mL per dispense) by placing an empty tube in the left side of the Single-
Tube Station.
NOTE Light blue coloring may be visible in the first diluent sample dispensed after Daily Checks or
after processing a sample in the R, CR, or CDR panel, when the Reticulocyte module is enabled. This
residual retic stain does not affect result accuracy. To obtain a clear diluent sample, discard the first
sample and dispense the diluent again.
2. Select PREDIx5 from the Test drop-down list on the Single-Tube Presentation dialog box.
3. Verify the Specimen Identifier and Test request.
4. Move the cursor to the end of the ID field by touching the end of the ID or using the
mouse to click at the end of the ID. Then, press [Enter]. Acknowledging the ID that is
displayed on the System Manager screen by pressing [Enter] indicates that you accept the
bar code label read or manual entry.
5. Place the pre-diluted specimen into the correct single-tube position.
IMPORTANT If more than two minutes elapse from the time the Specimen ID is entered to the
time the specimen is placed into the Single-Tube Presentation station, the station retracts and the
System Manager exits Single-Tube Presentation.
© 2018 Beckman Coulter Inc. All rights reserved. SOPDXH900_C06947
Page 23
Performing Complete Blood Count with WBC Differential, Nucleated Red Blood Cell, Reticulocyte and Body
Fluids Cell counting on the UniCel DxH 900
Maintenance
DxH 900 Procedure Purpose Tools/Supplies Frequency
High-quality,
fragrance-free,
Addresses: gel-free bleach (5-
Failure to recover 6% sodium
control values hypochlorite)
Cleaning (Bleaching)
Decreased cell Distilled water As needed
the Apertures
counted, increased Container for
MCV values, or bleach-distilled
increased voteouts water solution
Container for
distilled water
Cleaning the
Prevents damage to Soap
Pneumatic Supply As needed
the power supply Water
Module Fan Filter
Water
Cleaning the Handheld Removes accumulated Detergent
As needed
Bar Code Scanner dirt or dust Soft, lint-free cloth or
tissue
Limitations of the CBC, Diff, NRBC and Reticulocyte parameters may be affected by interferences. Confirmatory testing
Procedure within the laboratory should be performed to determine the source of unexpected abnormal results.
Body Fluid Cell counts may be affected by interferences as well.
Refer to the Instructions for Use or On-Line help, Chapter 1, System Overview, Limitations for more
information on interfering substances.
Interpretation of
Results Insert laboratory’s interpretations in the table below:
Analytical measuring range is the manufacturer-determined upper and lower limits of the amount,
Analytical activity, or potency of a specific analyte between which measurement is possible on the measuring
Measuring Range system within specific limits. This includes results from prediluted samples. Analytical measuring range
can be assessed using commercially available materials qualified for use on the DxH 900 System.
Operating Range Operating range is the range over which the system, inclusive of the predilute functionality, will report
(display, print and/or transmit) results. Values that are between the analytical measuring range and
operating range are flagged. The operating range usually exceeds the analytical measuring range.
Linearity Linearity can be assessed by testing levels of an analyte that are known by formulation or by using
commercially available materials qualified for use on the DxH 900 System. For instructions on
processing linearity results, see eIQAP on the Beckman Coulter website.
Specific Beckman Coulter recommends that a diluent be run as a Body Fluid sample prior to analysis of Body
Performance Fluid specimens. Backgrounds within specifications can influence the reported results on the samples
Characteristics with low abnormal or normal values. Beckman Coulter recommends that each laboratory establish
Specifications criteria for evaluation of the impact of background on the reported results.
DxH 900
Additional performance characteristics and specifications are shown in Chapter 1, System Overview,
Performance, in the Instructions for Use.
Reference A Normal Range study was conducted to assess the Reference Ranges for the DxH 900. Whole-blood
Range(s) samples were collected from approximately 240 donors (males and females). The selection of donors
was consistent with guidelines stated in CLSI EP28-A3c. Reference range values are shown in Chapter
1, System Overview, Performance, Reference Range Studies in the Instructions for Use. Each
laboratory should consider establishing its own normal ranges according to their respective
accreditation and/or regulatory requirements.
Reporting Results CBC, Diff, NRBC, Retic and Body Fluid parameter results are reported in the units of measure JAPAN,
SI-1, SI-2, SI-3, SI-4, SI-5, SI-6, US-1 and US-2. If any flags or alarms are present, or for additional
information, refer to the Instructions for Use, Chapter 6, Data Review.
CAUTION
Risk of erroneous results. Flags, Codes, and Messages are evaluated when the sample is
analyzed. Flags are reevaluated when results are manually edited, or when new results are
received for a pending sample. Flags (including Delta Checks) and Decision Rules are not
reevaluated upon a change of flagging limits for results already in the database.
Beckman Coulter does not claim to identify every abnormality in all samples. Beckman
Coulter suggests using all available options to optimize the sensitivity of instrument
results. All options include:
• Codes
• Flags
• Reference range limits
• Action limits
• Critical limits
• Delta checks
• Definitive messages
• System messages
• Suspect messages
• Status and exception messages
• Decision rules
Beckman Coulter recommends avoiding the use of one type of message or output to
summarize results or patient conditions. There may be situations where the presence of a
rare event may fail to trigger a suspect message.
Look for data patterns when examining Flags, Codes and Messages. For example, determine if some,
all, or related sets of results (for example, WBC and differential results) exhibit Flags, Codes and
Messages. For some parameters, flagging occurs as a result of the flagging or editing of other
parameters. In all cases, follow your laboratory’s policy for reviewing the sample.
Related UniCel DxH 900 Coulter Cellular Analysis System and Unicel DxH Slidemaker Stainer II
Procedures Coulter Cellular Analysis System
Instructions for Use
CHAPTER 1: System Overview
CHAPTER 2: Operation Principles
CHAPTER 3: Daily Checks
CHAPTER 4: Quality Control
CHAPTER 5: Sample Analysis
CHAPTER 6: Data Review
CHAPTER 7: Workload
CHAPTER 8: Shutdown
CHAPTER 9: Setup
CHAPTER 10: Troubleshooting
CHAPTER 11: Quality Assurance
CHAPTER 12: Cleaning Procedures
CHAPTER 13: Replacement/Adjustment Procedures
For additional system documentation, please refer to www.beckmancoulter.com > Support > Technical
Documents.
References 1. Kjeldsberg C, Knight J. Body Fluids: Laboratory Examination of Cerebrospinal, Seminal, Serous &
Synovial Fluids. 3rd Ed., ASCP Press, Chicago, IL 1993.
2. Miale JB, Laboratory Medicine - Hematology. 3rd Edition 1967, CV Mosby, pages 592-595
3. Steele R, Marmer D, O’Brien M, Tyson S, Steele C. Leukocyte survival in cerebrospinal fluid. J Clin
Micro, 198;23:965-966.
4. Guidelines for the evaluation of blood cell analyzers including those used for differential leucocyte and
reticulocyte counting and cell marker applications. International Council for Standardization in
Haematology: prepared by the ICSH expert panel on cytometry. Clin Lab Haematol, 16(2):157-174,
1994.
5. Coulter WH. High speed automatic blood cell counter and cell size analyzer. Paper presented at
National Electronics Conference, Chicago, IL, 1956; October 3.
6. Brecher G, Schneiderman M and Williams GZ. Evaluation of electronic red blood cell counter. AM J Clin
Path, 1956; 26:1439-1449.
7. Brittin GM, Brecher G and Johnson CA. Evaluation of the COULTER COUNTER Model S. Am J Clin Path,
1969,; 679-689.
8. Gottman AW. Multiple hematologic analyses by means of a COULTER COUNTER Model S. Paper
presented at
International Symposium of Standardization of Hematological Methods, Fondazione, Carlo Erba, Milan,
Italy, November 9 and 10. 1970. Symposium proceedings published in Haematologica Latina, 1969.
9. Hamilton PJ and Davidson RL. The interrelationships and stability of Coulter S-determined blood
indices. J Clin Path, 1973; 26:700-705.
10. Bessman JD and Johnson RK. Erythrocyte volume distribution in normal and abnormal subjects.
Blood, 1975; 46(3): 369-379.
11. Price-Jones C. The diameters of red cells in pernicious anaemia and in anaemia following
haemorrhage. J Path Bact, 1922; 25:487-504.
12. England JM, Walford DM and Waters DAW. Re-assessment of the reliability of the haematocrit. Brit J
Haemat, 1972; 23:247-256.
13. Bull BS, Scheiderman MA and Brecher G. Platelet counts with the COULTER COUNTER. Am J Clin
Path, 1965; 44(6):678-688.
14. Mundschenk DD, Connelly DP, White JG and Brunning RD. An improved technique for the electronic
measurement of platelet size and shape. J lab clin Med, 1976; 88(2):301-315.
15. Schultz J and Thom R. Electrical sizing and counting of platelets in whole blood. Med Biol Engr, 1973;
73:447-454.
16. Von Behrens WE. Mediterranean macrothrombocytopenia. Blood, 1975; 46(2):199-208.
17. Paulus JM. Platelet size in man. Blood, 1975; 469(3):321-336.
18. Eckhoff RF. An experimental indication of the volume proportional response of the Coulter Counter
for irregularly shaped particles. J Sci Inst, 1967; 44:648-649.
19. Grover NB, Naaman J, Ben-asson S and Dojanski F. Electrical sizing of particles in suspension III.
Rigid spheroids and red blood cells. Biophys J, 1972; 12:1099-1116.
20. Waterman CS, Atkinson EE, Wilkins B, Fischer CL and Kimsey SL. Improved measurement of
erythrocyte volume distribution by aperture-counter signal analysis. Clin Chem, 1975; 21:1201-1211.
21. Kachel V and Ruhenstroth-Bauer G. Methodik and Ergebissne Optiseher Formfatorunter-suchungen
bei der Zellvolumenmessung nach Coulter. Micros Acta, 1976; 75:419-423.
22. Gauthier J, Harel P, Belanger C and Fraysse J. Human leukocytes: their size distribution and mean
corpuscular volume. Can med Assoc J, 1967; 97:793-796.
23. Hughes-Jones NC, England JM, Norley I and Young JMS. Differential leucocyte counts by volume
distribution analysis. Brit J Haemat, 1974; 28(1):148.
24. England JM, Bashford CC, Hewer MG, Hughes-Jines NC and Down MC. A semi-automatic instrument
for estimating the differential leucocyte count. Biomed Engr, 1975; 10(8):303-304.
25. Wycherly PA and O’Shea MJ. Abridged differential leucocyte counts provided by a Coulter
Channelyzer in a routine haematology laboratory. J Clin Path, 1978.
26. Oberjat TE, Zucker TM and Cassen B. Rapid and reliable differential counts on dilute leukocyte
suspensions. J Lab Clin Med, 1970; 76(3):518-522.
References 27. Hoffman RA and Britt WB. Flow-system measurement of cell impedance properties. J Histochem
(cont.) Cytochem, 1979; 27(1):234-240.
28. Leif RC, Scwartz S, Rodriguez CM, Peel-Fernandez L, Groves M, Leif SB, Cayer M and Crews H. Two
dimensional impedance studies of BSA buoyant density separated human erythrocytes. Cytometry, 1985;
6(1):13-21.
29. Coulter WH et al. Signal modulated apparatus for generating and detecting resistive and reactive
changes in a modulated current path for particle classification and analysis. US Patent 3,502,974, March
24, 1970.
30. Fulwyler MJ. Electronic separation of biological cells by volume. Science, 1965; 150:910-911.
31. Loken MR, Sweet RG and Herzenberg LA. Cell discrimination by multiangle light scattering. J
Histochem Cytochem, 1976; 24(1):284-291.
32. Jovin TM, Morris SJ, Striker G, Schultens HA, Digweed M and Arndt-Jovin DJ. Automatic sizing and
separation of particles by ratios of light scattering intensities. J Histochem Cytochem, 1976; 24(1):269-
283.
33. Miale JB. Laboratory Medicine: Hematology. CV Mosby Company, St. Louis, MO, 4th ed., 1972; 22.
34. Corash L. Rheinschmidt M, Lieu S, Meers P and Brew E. Fluorescence-activated flow cytometry in the
hematology clinical laboratory. Cytometry, 1988; Supplement 3:60-64.
35. Friedman EW. Reticulocyte counts: How to use them, what they mean. Diagnostic Medicine, 1984;
7(6):29-33. 36. Williams WJ, Beutler E, Ersley AJ, and Lichtman MA. Hematology. McGraw-Hill, Inc, New
York, NY, 4th ed., 1990; 416.
37. Brecher G. New methylene blue as a reticulocyte stain. Am J Clin Path, 1949; 19:895-896.
38. International Committee for Standardization in Haematology. Recommendations for reference
method for haemoglobinometry in human blood (ICSH Standard EP 6/2: 1977) and specifications for
international haemiglobincyanide reference preparation (ICSH Standard EP 6/3: 1977). J Clin Path, 1978;
31(2):1390143.
39. Dorsey DB. What can quality control do for hematology? Am J Med Tech, 1965; Mar-Apr:150-153.
40. Bull BS. A statistical approach to quality control. Quality Control in Hematology. Symposium of the
International Committee for Standardization in Haematology. Lewis SM and Coster JF, eds, Academic
Press, London, England, 1975.
41. Koepke JA and Protextor TJ. Quality assurance for multichannel hematology instruments. Am J Clin
Path, 1981; 75(1):28-33.
42. Bull BS. A statistical approach to quality control. Quality Control in Hematology, Symposium of the
International Committee for Standardization in Haematology. Lewis SM and Coster JF, eds, Academic
Press, London, England, 1975.
43. Bowles K.M., Cook L.J., Richards E.M., Baglin T.P, Platelet size has diagnostic predictive value in
patients with thrombocytopenia, Clin. Lab Haem. 27:370–373, 2005.
44. Bancroft A. J., Abel E. W., Mclaern M. . Belch J. J. F. , Mean platelet volume is a useful parameter: a
Reproducible routine method using a modified Coulter Thrombocytomer, Platelets 11:379–387, 2005.
45. EP09-A3 Measurement procedure comparison and bias estimation using patient samples, approved
guideline- third edition; 8/30/2013. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA.
46. EP28-A3c Defining, establishing, and verifying reference intervals in the clinical laboratory, approved
guideline - third edition; 10/19/2010. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA.
47. GP41-A6 (formerly H3-A6) Procedures for the collection of diagnostic blood specimens by
venipuncture, approved standard - sixth edition; 10/31/2007. Clinical and Laboratory Standards Institute
(CLSI), Wayne, PA.
48. GP42-A6 (formerly H4-A5) Procedures and devices for the collection of diagnostic capillary blood
specimens, approved standard - sixth edition; 9/23/2008. Clinical and Laboratory Standards Institute
(CLSI), Wayne, PA.
49. GP44-A4 Procedures for the handling and processing of blood specimens for common laboratory
tests; approved guideline - fourth edition; 5/25/2010. Clinical and Laboratory Standards Institute (CLSI),
Wayne, PA.
50. H07-A3 Procedure for determining packed cell volume by the microhematocrit method, approved
standard- third edition; 10/1/2000. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA.
References 51. H15-A3 Reference and selected procedures for the quantitative determination of hemoglobin in
(cont.) blood, approved standard - third edition; 12/1/2000. Clinical and Laboratory Standards Institute (CLSI),
Wayne, PA.
52. H20-A2 Reference leukocyte (WBC) differential count (proportional) and evaluation of instrumental
methods; 1/18/2007 - approved standard - second edition. Clinical and Laboratory Standards Institute
(CLSI),Wayne, PA.
53. Turgeon, M. Clinical Hematology: Theory and Procedures. Lippincott, Williams, & Wilkins,
Baltimore, MD, 4th ed., 2005.
54. GP40-A4-AMD Preparation and testing of reagent water in the clinical laboratory; 6/2012 -
approved guideline - fourth edition. Clinical and Laboratory Standards Institute (CLSI), Wayne,
PA.
Additional UniCel DxH 900 Coulter Cellular Analysis System and Unicel DxH Slidemaker Stainer II
Information Coulter Cellular Analysis System
C06947AB
For additional system documentation, please refer to www.beckmancoulter.com > Support > Technical
Documents.
Trademarks
Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned
herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other
countries.
All other trademarks, service marks, products, or services are trademarks or registered trademarks of
their respective holders.
Appendices/
Attachments
REVIEWS/APPROVALS
ANNUAL REVIEW